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Objectives. We sought to determine the ability of a treadmill
score to provide accurate diagnostic and prognostic risk estimates
in women.
Background. Treadmill testing has been reported to have a
lower accuracy for diagnosis of chest pain in women. The diag-
nostic and prognostic value of the Duke Treadmill Score (DTS) in
women is unknown.
Methods. We determined the diagnostic and prognostic value of
the DTS in 976 women and 2,249 men who underwent both
treadmill testing and cardiac catheterization in a single institu-
tion from 1984 to 1994.
Results. Women and men differed significantly in DTS (1.6
vs. 20.3, p < 0.0001), disease prevalence (32% vs. 72% significant
coronary artery disease [CAD], p < 0.001), and 2-year mortality
(1.9% vs. 4.9%, p < 0.0001). The DTS provided information
beyond clinical predictors of both coronary disease and survival in
women and men. Although overall women had better survival, the
DTS performed equally well in stratifying both genders into
prognostic categories. The DTS actually performed better in women
than in men for excluding disease, with fewer low risk women having
any significant coronary disease (>21 vessel with >75% stenosis)
(20% vs. 47%, p < 0.001), or severe disease (3-vessel disease or >275%
left main stenosis) (3.5% vs. 11.4%, p < 0.001).
Conclusions. By combining several aspects of treadmill testing,
the DTS effectively stratifies women into diagnostic and prognos-
tic risk categories.
(J Am Coll Cardiol 1998;32:1657–64)
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Women presenting with chest pain differ from men in aspects
of their clinical presentation, performance on diagnostic tests
and in the prevalence of coronary artery disease. These
differences alter pretest likelihood, referral patterns and the
diagnostic ability of tests. The fact that most of the available
data on the noninvasive diagnosis of chest pain is based on
studies in men provides as additional challenge in the evalua-
tion of women (1,2). The standard exercise electrocardio-
gram (ECG) is the most commonly used and least costly of
noninvasive tests for the assessment of ischemic heart
disease. This test, however, appears to be less accurate in
women for the diagnosis of coronary disease due in part to
an increase rate of false positives (3–9). For example, recent
meta-analyses have found a statistically significant lower
specificity of ST segment depression on treadmill tests in
women compared with men (10,11). As a consequence,
many clinicians believe that a stress-imaging study should be
the test of first choice for the diagnostic evaluation of chest
pain in women.
Although the interpretation of the exercise test as “posi-
tive” or “negative” has traditionally been based on the pres-
ence of ST segment depression, the exercise test provides a
variety of other diagnostic and prognostic indicators, including
exercise capacity and symptoms, which are useful in test
interpretation (12). By interpreting all the information as a
composite score, the diagnostic ability of treadmill testing in
women may increase. The Duke Treadmill Score (DTS), a
weighted index combining ST segment deviation, treadmill
time and exercise-induced angina, was developed and vali-
dated as a risk-prediction instrument in a predominately male
population (13,14). Recently, it has also been shown in a
predominately male population to stratify risk of significant
and severe coronary disease (15). Because of its demonstrated
prognostic ability, the DTS has been included in the recom-
mended screening algorithms of the Agency for Health Care
Policy and Research (AHCPR) Unstable Angina Guidelines
and the newly revised ACC/AHA (American College of
Cardiology/American Heart Association) Guidelines for
Exercise Testing (9,16). To date, however, the diagnostic
and prognostic accuracy of the DTS in women has not been
fully evaluated. The purpose of the present study was to
assess the diagnostic and prognostic performance of the
DTS in almost 1,000 women undergoing treadmill testing
and cardiac catheterization.
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Methods
Patient population. We identified 3,225 patients referred
for evaluation of chest pain who underwent exercise treadmill
testing and subsequent diagnostic cardiac catheterization at
Duke University Medical Center from 1984 to 1994. Of these,
30% were women (n 5 976). Inclusion criteria were cardiac
catheterization performed within 90 days of exercise treadmill
testing. Exclusion criteria were prior cardiac catheterization or
revascularization procedure, significant valvular or congenital
heart disease, acute MI (myocardial infarction) on presentation,
or resting ST-T wave changes from conditions such as bundle
branch block in the baseline 12-lead ECG that would interfere
with the interpretation of the standard exercise stress test.
Clinical, catheterization and follow-up data. Baseline clin-
ical, exercise stress test and catheterization results were col-
lected prospectively and entered into a computerized data
base. Follow-up data were obtained by mailed questionnaire
or telephone interview at 6 months and 1 year postcatheteri-
zation, and yearly thereafter as previously described (13,14). All
cardiac deaths were confirmed with clinical data or death cer-
tificate by reviewers unaware of the clinical, angiographic or
exercise stress data. Two-year follow-up for survival was 97%
complete.
Exercise treadmill testing. All patients underwent
symptom-limited treadmill testing using the standard Bruce
protocol (13,14). A 12-lead ECG was recorded before exercise,
at the end of each exercise stage, at peak exercise and at 2-min
intervals during recovery. Three standard ECG leads were
continuously monitored during exercise. The test was discon-
tinued for limiting symptoms (angina, dyspnea, fatigue), ab-
normalities of rhythm or blood pressure, or marked and
progressive ST segment deviation (.0.2 mV in the presence of
typical angina or in the first stage of exercise). The ECG
criterion for a positive test was 1 mm or more of exercise-
induced ST segment deviation at 0.06 after the J point, relative
to the PR segment.
Duke Treadmill Score. The Duke Treadmill Score (DTS)
was calculated by inserting a patient’s test results into the
following formula:
DTS 5 Exercise time 2 ~5 3 ST deviation! 2 ~4 3 treadmill angina!
Exercise time is measured in minutes, ST deviation is the
largest net deviation, either depression or elevation in any lead
except (aVR), and treadmill angina is graded on the following
scale: 0 5 no angina during exercise, 1 5 nonlimiting angina
during exercise, and 2 5 exercise-limiting angina. The distinc-
tion between exercise-induced angina and nonanginal chest
pain is based on the supervising clinician’s judgment with
particular emphasis on reproduction of the patients presenting
symptoms and on the classic features of typical angina. The
typically observed range for the DTS is 225 (highest risk)
to 115 (lowest risk). In this study, we used a previously
proposed subgrouping system for the DTS: low risk (DTS
score $5), moderate risk (DTS score between 5 and 211) and
high risk (DTS score #211) (13).
Statistical analyses. For descriptive purposes, continuous
variables were presented as medians (25th and 75th quartiles)
and discrete variables as percentages. Statistical comparisons
were made between men and women. The Wilcoxon rank-sum
test was used to assess differences in continuous variables, and
chi-square tests were used for discrete variables. Outcomes
evaluated were significant coronary artery disease, severe
coronary artery disease and survival. Significant coronary
artery disease was defined as $75% diameter stenosis in one
or more vessels, and severe disease, a subset of significant
disease, was defined as $75% stenosis in three vessels or
$75% left main stenosis.
The prognostic value of the DTS was examined in three
ways. First, to examine the empirical risk stratification pro-
vided by the DTS, Kaplan-Meier survival curves were gener-
ated separately for women and men stratified by the three DTS
risk categories (17). In this analysis, patients who subsequently
underwent coronary revascularization were censored at the
time of their procedure. Second, to test whether the DTS
performed differently in women and men, we introduced an
interaction term (gender by DTS) into the Cox model with
DTS and gender and tested for its significance (18). Finally, we
added independent clinical history and physical examination
prognostic factors to the Cox model, and we tested for the
predictive contribution of the DTS by comparing the model
containing only clinical data to the model containing both
clinical data and the DTS (Appendix) (19). The difference in
the overall likelihood ratio chi-squares between the models
was used to quantitate the incremental contribution of the
DTS to the overall model of prognosis in women and men.
The diagnostic value of the DTS was examined in three
ways. First, the probability of significant and severe coronary
disease in women and men was plotted from logistic regression
models including DTS and gender. The extent of coronary
disease found at catheterization was correlated with DTS risk
categories. Second, to compare diagnostic accuracy by gender,
we used these logistic regression models, and we tested for the
significance of an interaction term (gender by DTS) that would
indicate differential effects of DTS on likelihood of significant
or severe coronary disease due to gender. Finally, we added
independent clinical history and physical exam diagnostic
factors to test whether the DTS added diagnostic information
to the baseline clinical data in men and women (Appendix)
(20,21). We compared the models containing only clinical data
to those containing both clinical data and the DTS. The
difference in the overall likelihood ratio chi-squares between
the models was then used to quantitate the incremental
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contribution of the DTS to the overall model for significant
and severe disease in women and men.
Results
Baseline characteristics and test results. The baseline
characteristics of the women and men in the study cohort are
shown in Table 1. Women were slightly older (51 vs. 50 years,
p 5 0.02), more likely to have hypertension (39% vs. 34%, p 5
0.004) and were more likely to report atypical chest pain (53%
vs 34% p , 0.001). Men were more likely to have had a prior
MI (34% vs. 14%, p , 0.001) and to report typical angina
(55% vs. 28%, p , 0.001).
The baseline exercise stress test variables and angiographic
data are shown in Table 2. Women had shorter exercise
duration (5.5 min vs 7.0 min, p , 0.001), a lower prevalence of
ST segment depression (19% vs. 37%, p , 0.001) and less
exercise-induced angina than men (42% vs. 54%, p , 0.001).
The majority of women and men had moderate risk treadmill
scores (63% and 54%), with most of the remaining women and
men in the low risk group (33% and 34%), and only a few of
either gender in the high risk group 4% and 12%). Overall, the
distribution of scores for women was shifted up (toward lower
risk) relative to that for men (median treadmill score 1.6
vs 20.3, p , 0.0001). At cardiac catheterization, women were
much less likely to have significant coronary disease when
compared with men (32% vs. 72%, p , 0.001).
Prognostic ability for gender. The 2-year mortality was
1.9% for the study women compared with 4.9% for the men.
Mortality increased for higher-risk DTS groups in both gen-
ders (Fig. 1). Two-year mortality for women was 1.0%, 2.2%
and 3.6%, respectively for low, moderate, and high risk groups.
Two-year mortality for men was 1.7%, 5.8% and 16.6%,
respectively for low, moderate, and high risk groups. Both
gender and the DTS were independent predictors of sur-
vival, but the interaction term between gender and the DTS
in this model was not significant (p 5 0.093), suggesting a
similar relative relationship between DTS and prognosis for
both genders (Table 3).
When the DTS was added to a Cox model containing the
independent clinical predictors of survival, it contained 7.5%
of the total prognostic information available in women and
20.8% of that available in men (Table 4).
Diagnostic ability by gender. At every DTS risk level,
women had less coronary artery disease than did their male
counterparts. Over 80% of the women with low risk scores had
no significant coronary artery disease at catheterization com-
pared with 52.6% of the men with low risk scores (Table 5).
Similarly, only 3.5% of low risk women had severe coronary
disease, compared with 11.4% of low risk men. The majority of
women with moderate risk scores frequently had no significant
coronary disease (65.1%), but over one-third also had signifi-
cant disease (34.9%), or severe coronary disease (12.4%). By
contrast, only a few men with moderate risk scores had no
coronary disease (17.8%), whereas the majority had significant
disease (82.2%) or severe disease (38.7%). Patients of either
gender with high risk scores frequently had severe coronary
disease (46% of women and 71.5% of men). Graphs of the
probability of significant and severe coronary artery disease
plotted for DTS by gender reveal similar shapes to the
curves, although women had less disease at every DTS value
compared with men (Figs. 2 and 3). Both DTS and gender
contributed significantly independent information for the
prediction of significant and severe coronary artery disease
(Table 3).
An interaction term between the DTS and gender of border-
line significance was found for the prediction of significant disease
(p 5 0.046), but not for severe disease (p 5 0.211). When the
components of the DTS were tested individually to discover the
source of this gender interaction, an interaction term also of
Table 1. Baseline Clinical Characteristics
Variable
Women
30% (n 5 976)
Men
70% (n 5 2,249)
Age* 51 (45, 57) 50 (43, 57)**
Hypertension 39% 34%**
Hyperlipidemia 22% 24%
Diabetes 10% 9%
Prior myocardial infarction 14% 34%**
Typical angina 28% 55%**
Atypical angina 53% 34%**
Congestive heart failure 5% 6%
Symptom duration (months)* 16 (6, 48) 16 (5, 54)
Chest pain (episodes/week)* 5 (2, 11) 5 (2, 11)
*Median (25th, 75th quartiles). **p , 0.05 for comparison across gender;
others NS.
Table 2. Exercise Test Variables, DTS Groups and Cardiac
Catheterization Results
Variable Women Men**
Treadmill Testing
ST Depression $ 1.0 mm 19% 37%
Exercise time (min)* 5.5 (3.5, 7.1) 7.0 (4.3, 9.5)
Exercise angina 42% 54%
Peak heart rate* 140 (122, 147) 141 (131, 147)
Duke Treadmill Score
Treadmill score* 1.6 (21.4, 6) 20.3 (26.5, 7)
Low risk (5 5) 33% 34%
Moderate risk (4 to 210) 63% 54%
High risk (5 211) 4% 12%
Cardiac Catheterization
No stenosis 5 75% 68% 28%
1 VD 5 75% 13% 17%
2 VD 8% 22%
3 VD or LM 11% 33%
Ejection fraction* 60 (58, 65) 59 (48, 61)
Survival
2-Year mortality 1.9% 4.9%
LM 5 left main; VD 5 vessel disease. *Median (25th, 75th quartiles). **All
comparisons across gender are significant to p , 0.05 level or greater.
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borderline significance was found between gender and the angina
component of the treadmill score (p 5 0.048). This suggests a
differential relationship exists between angina and the prediction
of significant coronary disease in women compared with men.
Women have a similar frequency of angina on the treadmill as do
men, but exercise angina in women was less often correlated with
the presence of coronary artery disease. When the angina com-
ponent of the DTS was removed, the score’s ability to diagnose
significant disease in women was essentially unchanged (area
under ROC [receiver operating characteristic] 0.694 vs. 0.697). In
men, however, deletion of the angina component diminished the
predictive value of the score for significant coronary disease (area
under ROC 0.806 vs. 0.792).
When the DTS was added to the model with clinical
predictors of coronary disease, it provided significant incre-
mental information in both men and women. For significant
disease, DTS provided 11.3% of the total information in
women, and 13.9% of the total information in men. For severe
disease, DTS added 18.5% of the total predictive information
in women, and 26.9% in men (Table 4).
Figure 1. Kaplan-Meier curves for 2-year survival shown for
men and women with low (dashed line), moderate (dotted
line) and high (solid line) risk Duke Treadmill Scores.
Table 3. Multivariable Models Testing for Interaction Between the
DTS and Gender for the Diagnosis of Significant, Severe Disease,
and Survival
Significant
(x2)
Severe
(x2)
Survival
(x2)
Duke Treadmill Score 363.8* 365.1* 153.2*
Gender 378.6* 101.6* 31.2*
Interaction (DTS* gender) 3.98** 1.6 2.8
*p 5 0.0001. **p 5 0.046.
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Discussion
The evaluation of chest pain in women can be simple and
cost-efficient. In the largest study of treadmill testing in
women to date, we demonstrated equivalent diagnostic and
prognostic ability to the Duke Treadmill Score (DTS) in
women and men. As has been shown in previous popula-
tions, women in our study presenting for chest pain evalu-
ation had less coronary artery disease and performed dif-
ferently on the treadmill from men (5,7). Despite this, we
found that the DTS, by combining several standard mea-
sures available from exercise treadmill testing, is able to
accurately risk-stratify both genders for the presence of
disease and survival and adds information beyond clinical
factors in both women and men.
Comparison to prior studies. Because standard interpreta-
tion of exercise treadmill testing has lower specificity and
positive predictive value in women, many investigators have
attempted to improve the diagnostic accuracy of treadmill
testing in women by creating new variables such as ST/HR
(heart rate) slope, computer-generated algorithms and gender-
specific guidelines for interpretation (4,22–24). Because these
methods have not found widespread clinical acceptance, others
have suggested that initial testing strategies in women exclude
standard treadmill testing in favor of exercise or stress-imaging
studies (25–28). In the current study, we found that the
combination of several variables from treadmill testing into a
single composite risk score provided equivalent risk stratifica-
tion in men and women. There was no gender interaction
Figure 2. Probability of significant
disease at catheterization across
Duke Treadmill Scores for men (sol-
id line) and women (dashed line) as
the result of a logistic model contain-
ing DTS and gender. Vertical lines
divide the Duke Treadmill Scores
into high risk (5 211), moderate risk
(between 211 and 5) and low risk (5
5).
Table 4. Incremental Information Provided by Duke Treadmill
Score Over Clinical Predictors for Significant Disease
Clinical Index*
(x2)
Clinical Index
and DTS (x2)
% Information Contributed
by DTS
Significant Disease
Men 920.1 1068.7 13.9%
Women 322.3 363.2 11.3%
Severe Disease
Men 486.2 664.9 26.9%
Women 141.8 173.9 18.5%
Survival
Men 197.9 250.1 20.8%
Women 63.7 68.9 7.5%
*Clinical Index for the diagnosis of significant, severe disease and survival
(see Appendix).
Table 5. Frequency of Coronary Disease Subsets in Women and Men
Duke Treadmill Score
No Stenosis
$ 75%
1 VD
$ 75%
2 VD
5 75%
3 VD 5
75% or LM
Women (n 5 976)
Low risk (33%) 80.9% 9.4% 6.2% 3.5%
Moderate risk (63%) 65.1% 14.2% 8.3% 12.4%
High risk (4%) 10.8% 18.9% 24.3% 46%
Men (n 5 2246)
Low risk (34%) 52.6% 22.4% 13.6% 11.4%
Moderate risk (54%) 17.8% 15.6% 27.9% 38.7%
High risk (12%) 1.8% 9.1% 17.5% 71.5%
LM 5 left main; VD 5 vessel disease.
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between the DTS and the diagnosis of severe coronary disease
and the prediction of survival. The borderline gender interac-
tion between the DTS and the diagnosis of significant disease
was largely explained by the weaker relationship between
angina and the presence of coronary artery disease in women.
Removing the angina component from the DTS did not
significantly change its diagnostic ability in women because
treadmill time and ST deviation substitute more of the
diagnostic information in women. This emphasizes the
advantage of interpreting results of treadmill testing as a
composite score.
Clinical significance of treadmill scores. Our analysis
showed that predictions for women should be interpreted
within the context of lower pretest risk for both diagnostic and
prognostic risk stratification. Because of differences in disease
prevalence, women had better survival at all values of the DTS.
Risk categories were essentially shifted down one level of
severity in women. The three treadmill risk categories of low,
moderate, and high risk in men corresponded to very low, low,
and moderate risk in women. In essence, owing the lower
prevalence of disease in women, a low risk DTS was actually
better at excluding coronary artery disease in women than in
men. Although many low risk men can be managed without
additional invasive testing, this is true for both low and
moderate risk women. Therefore, renewed confidence in the
initial use and interpretation of treadmill testing in women
should be encouraged, especially for the purpose of excluding
coronary artery disease.
Study limitations. The population in our study consisted of
inpatients who underwent cardiac catheterization as part of
their initial cardiac evaluation. Although this is necessary to
determine diagnostic accuracy of treadmill testing, it creates a
potential bias toward patients with a higher likelihood of
disease. The prognostic accuracy of the Duke Treadmill Score
has been previously tested and validated in an outpatient
population, but this latter population did not have enough
women to examine this subgroup separately. Furthermore,
though our population of 976 women was smaller than
comparable studies in men, it still represents one of the
largest assessments of treadmill accuracy in women. In
addition, our findings only apply to patients who are candi-
dates for exercise treadmill testing, who are physically able
to walk on a treadmill and have no resting abnormalities on
their ECG.
Conclusions. In the largest study to date of women
undergoing treadmill testing, we demonstrated that the DTS
can accurately stratify diagnostic and prognostic risk in
women. Our results support the routine initial use of the
exercise treadmill test in suitable candidates of both genders
presenting with suspected coronary artery disease, as
recommended by the new ACC/AHA Exercise Testing
Guidelines.
The authors would like to acknowledge the excellent editorial and technical
support of Ms. Tracey Simons in the preparation of the manuscript.
Figure 3. Probability of severe dis-
ease at catheterization across Duke
Treadmill Scores for men (solid line)
and women (dashed line) as the result
of a logistic model containing DTS
and gender. Vertical lines divide the
Duke Treadmill Scores into high risk
(5 211), moderate risk (between
211 and 5) and low risk (5 5).
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Appendix
Clinical Index Models for the Prediction of Disease and Survival
1. Predictive Characteristics and Coefficients for Cox Proportional Hazards
Model Predicting Survival (19)
Characteristics Coefficient
Prognostic pain index (episodes of daily angina * (6 * unstable
angina 1 2 * progressive angina 1 nocturnal angina 1 3 *
presence of ST-T wave changes* [1–0.5 * (ECG Q
waves)]))
0.0364
Myocardial index (History of CHF 1 2 * class IV CHF 1
cardiomegaly 1 ECG PVCs 1 ventricular gallop 1 2 *
[history of previous MI or Q waves])
0.4506
Vascular disease index (history of peripheral vascular disease
1 history of cerebrovascular disease 1 presence of carotid
bruits)
0.5333
Conduction index (4 * ECG LBBB 1 1 * ECG RBBB 1 2 *
ECG LAD 1 4 * ECG IVCD)
0.8975
Age 0.02260
Sex (0 5 male, 1 5 female) 20.6732
Typical angina 0.2952
Centering constant 21.8833
2. Predictive Characteristics and Coefficients in Logistic Multiple Regression
Model for the Prediction of Significant Coronary Disease (20)
Characteristics Coefficients
Age 0.1126
Sex (0 5 male, 1 5 female) 20.328
Age * Sex (interaction) 20.0301
Typical angina (1 if present) 2.581
Atypical angina (1 if present) 0.976
History of MI (1 if present) 1.093
ECG Q waves (1 if present) 1.213
History of MI * Q waves (interaction) 0.741
Smoking (1 if present) 2.596
Hyperlipidemia (1 if present) 1.845
Diabetes (1 if present) 0.694
ECG ST-T wave changes (1 if present) 0.637
Age * Smoking (interaction) 20.0404
Age * Hyperlipidemia (interaction) 20.0251
Sex * Smoking (interaction) 0.550
3. Predictive Characteristics and Coefficients in Logistic Multiple Regression
Model for the Prediction of Severe Coronary Disease (21)
Characteristics Coefficients
Log10 of duration of CAD 1 1 0.3424
Type of pain (0 5 nonanginal, 1 5 atypical, 2 5 typical) 0.3014
Log10 of duration 1 1) * type of pain (interaction) 0.1559
Age 0.0299
ECG Q waves (1 if present) 0.3513
Pain index (typical angina * episodes weekly angina
[maximum, 35]) * 1 * progressive pain 1 4 ST-T waves but
no Q waves 1 2 * presence of nocturnal angina)
0.0054
Sex (0 5 male, 1 5 female) 20.3823
Risk factor index (hyperlipidemia 1 diabetes 1 hypertension) 0.1734
Vascular disease index (history of peripheral vascular disease
1 history of cerebrovascular disease 1 presence of carotid
bruits)
0.2402
Appendix abbreviations: CHF 5 congestive heart failure; IVCD 5 intraven-
tricular conduction defect; LAD 5 left axis deviation; LBBB 5 left bundle-
branch block; MI 5 myocardial infarction; PVCs 5 premature ventricular
contractions; RBBB 5 right bundle-branch block.
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